Mustang Bio (MBIO) Interest Coverage Ratio (QoQ) (2016 - 2025)
Mustang Bio (MBIO) Interest Coverage Ratio (QoQ) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Mustang Bio | 3.90 Mn | 3.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 62.97% |
| Dec 31, 2024 | 99.45% |
| Sep 30, 2024 | -49,564.25% |
| Jun 30, 2024 | 84.91% |
| Mar 31, 2024 | -100.67% |
| Dec 31, 2023 | 213.08% |
| Sep 30, 2023 | -54,287.96% |
| Jun 30, 2023 | 70.27% |
| Mar 31, 2023 | -174.53% |
| Dec 31, 2022 | 68.15% |
| Sep 30, 2022 | 6.57% |
| Jun 30, 2022 | 77.15% |
| Mar 31, 2022 | 98.30% |
| Dec 31, 2021 | 11.64% |
| Sep 30, 2021 | -57.68% |
| Jun 30, 2021 | -11,935.73% |
| Mar 31, 2021 | -238.44% |
| Dec 31, 2020 | -128.38% |
| Sep 30, 2020 | 82.99% |
| Jun 30, 2020 | -62.38% |